Annual PHARMACCESS LEADERS FORUM 2014
October 8 - 10, 2014
Various options and decision-making tools exist, some old, some novel. Traditional decision making based on, for example, price referencing, DRGs budgets or generic substitution are still significant. However, recent advances in the sophistication of HTA analysis and modeling, flexible pay for performance models, risk-sharing and value-based pricing schemes have become increasingly important to mitigate payer risk and allocate financial resources to the areas of pressing need. Savings and outcome improvements can also be found through finding efficiency gains at the healthcare delivery level, providing the right incentives for prescribers and improving patient adherence.
3 EVENTS IN ONE:
1. International Pharmaceutical Payers & HTA Summit
2. Among Action: Experiences With the German Pharmaceutical Pricing & Reimbursement Reform
3. Market Access for High Value Speciality & Biologic Medicines
Request agenda at http://autumnpharmaccess2014.nextlevelpharma.com/request-agenda .
3 EVENTS IN ONE:
1. International Pharmaceutical Payers & HTA Summit
2. Among Action: Experiences With the German Pharmaceutical Pricing & Reimbursement Reform
3. Market Access for High Value Speciality & Biologic Medicines
Request agenda at http://autumnpharmaccess2014.nextlevelpharma.com/request-agenda .
Venue
Sorry, this event is quite new so we couldn't find any venue information.
Please check again in the near future.
Please check again in the near future.
Organizer
Related events
Annual PHARMACCESS LEADERS FORUM October 8 - 10, 2014